PCI Biotech receives positive opinion on Fimaporfin for CC

Discussion Forum Discussion Forum Clinical Trials and Treatments PCI Biotech receives positive opinion on Fimaporfin for CC

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #9329

    Helen_ammf
    Moderator

    PCI Biotech, the cancer focused Norwegian biopharmaceutical company have recently announced that they have received a positive opinion from the European Medicine Agency’s Committee for Orphan Medicinal Products for fimaporfin, for treating cholangiocarcinoma.

    Details on the trial Prof Dan Palmer and Dr Richard Sturgess are running in Liverpool using PCI’s fimaporfin (Amphinex), can be found on AMMF’s clinical trials page under the heading ‘PCI and Chemotherapy’:

    https://ammf.org.uk/clinical-trials/

    To read PCI Biotech’s press release about fimaporfin, go to:

    http://pcibiotech.no/bile-duct-cancer/

    • This topic was modified 1 year, 6 months ago by M.
Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.